W 0101 companion diagnostic - Pierre Fabre/Roche
Alternative Names: W-0101 companion diagnostic - Pierre Fabre/RocheLatest Information Update: 19 Mar 2021
At a glance
- Originator Pierre Fabre
- Developer Pierre Fabre; Roche
- Class Antibody diagnostics; Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II Cancer
Most Recent Events
- 19 Mar 2021 Phase I/II trial is still ongoing in Cancer in France and Spain (unspecified route) (NCT03316638)
- 18 May 2018 Phase-I/II clinical trials in Cancer (Diagnosis) in Spain (unspecified route), after March 2018 (NCT03316638)
- 18 May 2018 Pierre Fabre and Roche extend an earlier agreement to co-develop W 0101 companion diagnostic for Cancer